In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd. Mandar Wagh / Friday, March 8, 2024 / Article rating: 4.6 Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd.
Market Wrap: Benchmark indices close on a negative note with Nifty FMCG and Nifty PSU... Market Wrap: Benchmark indices close on a negative note with Nifty FMCG and Nifty PSU... Sensex closed lower by 0.14 per cent and closed at 77,580.31, while Nifty closed lower...
Penny Stock Under Rs 10: Company Secures Service Contract with UAE-based Erhardt... Penny Stock Under Rs 10: Company Secures Service Contract with UAE-based Erhardt...
Promoter Bought 5,37,000 Shares: Microcap Company Reports Stellar Q2 FY25 Results –... Promoter Bought 5,37,000 Shares: Microcap Company Reports Stellar Q2 FY25 Results –...
Penny Stock with High Promoter Holding: Revenue Jumps 2,357 Per cent, Profit Climbs... Penny Stock with High Promoter Holding: Revenue Jumps 2,357 Per cent, Profit Climbs...
Axis Mutual Fund and HSBC Mutual Fund Take Fresh Positions in 2024-Listed Company;... Axis Mutual Fund and HSBC Mutual Fund Take Fresh Positions in 2024-Listed Company;... During the period of July to September domestic mutual funds Axis Midcap Fund and HSBC...
Top Mistakes to Avoid While Investing in Mutual Funds Top Mistakes to Avoid While Investing in Mutual Funds
Dollex & Defty: What Do These Terms Mean in the Stock Market? Dollex & Defty: What Do These Terms Mean in the Stock Market?